Investor Presentation of the Earnings call scheduled today i.e. on July 30, 2026

July 30, 2026 Ref: NIVABUPA/EQ/2026-27/27 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Dalal Street, Mumbai – 400 001 Symbol: NIVABUPA Scrip Code: 544286 Sub: Presentation of Earnings call Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Please find enclosed presentation to be made at the Earnings call today, on the business performance for the quarter ended June 30, 2026. The presentation shall also be hosted on the website of the Company at www.nivabupa.com . This is for your information and records. Thanking You, Yours Sincerely, For Niva Bupa Health Insurance Company Limited Aparna Sharma Company Secretary and Compliance Officer Niva Bupa Health Insurance Company Limited IRDAI Registration No. 145 | CIN: L66000DL2008PLC182918 Registered Office: C-98, First Floor, Lajpat Nagar, Part 1, Delhi-110024 Corporate Office: 3rd Floor, Capital Cyber scape, Golf Course Extension Road, Sector-59, Gurugram-122101, Haryana. Website: www.nivabupa.com | Email id: investor@nivabupa.com I Tel: +91-124-6354900 Investor Presentation Q1’FY2027 Disclaimer The contents of this presentation are for informational purposes only. The contents are intended, but not guaranteed, to be correct, complete, or absolutely accurate. This presentation may contain certain words or phrases which are not statements of historical facts and may be described as “forward-looking statements”. These forward-looking statements generally can be identified by words or phrases such as “aim”, “anticipate”, “are likely”, “believe”, “continue”, “can”, “shall”, “could”, “expect”, “estimate”, “intend”, “may”, “likely” “objective”, “plan”, “project”, “propose”, “seek to”, “will”, “will continue”, “will achieve”, “will likely”, “will pursue” or other words or phrases of similar import. Similarly, statements that describeourCompany’s strategies,objectives,plansor goals,financial andoperatingprojectionsarealsoforward-lookingstatements. All forward-looking statements are subject to risks, uncertainties, expectations and assumptions about us that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement. Actual results may differ materially from those suggested by the forward-looking statements due to risks or uncertainties associated with our expectations with respect to, but not limited to, regulatory changes pertaining to the industry in which our Company operates and our ability to respond to them, our ability to successfully implement our strategy, our growth and expansion, technological changes, our exposure to market risks, general economic and political conditions in India and globally which have an impact on our business activities, investments, or the industry in which we operate, the monetary and fiscal policies of India, inflation,deflation,unanticipated turbulenceininterestrates,foreignexchange rates,equityprices or otherrates or prices,the performance of the financial markets in India and globally, changes in domestic laws, regulations, taxes, changes in competition in the industry in which we operate andincidentsof anynaturalcalamitiesand/oractsof violence. Forward-looking statements reflect the current views of our Company as of the period of these results and are not a guarantee of future performance.Thesestatementsarebased onour management’s beliefs,assumptions,current plans,estimatesand expectations,which inturnare based on currently available information. Although we believe the assumptions upon which these forward-looking statements are based are reasonable, any of these assumptions could prove to be inaccurate, and the forward-looking statements based on these assumptions could be incorrect.We undertakeno obligationto updateforward-lookingstatementsto reflecteventsor circumstancesafterthe datethere. The Company disclaims any obligation or liability to any person for any loss or damage caused by errors or omissions, whether arising from negligence or any other cause. Recipients of this presentation are not to construe its contents, or any prior or subsequent communications from or with the Company or its representatives as investment, legal or tax advice. In addition, this presentation does not purport to be complete or contain all information that may be required to make a full analysis of the Company. These materials do not constitute or form part of any offer or solicitationto purchaseor subscribefor securitiesof the Company. OUR PURPOSE To give every Indian the confidence to access the best healthcare Notes: MD & CEO Commentary on Q1’FY2027 Performance The Indian economy enters the new financial year after a strong FY2026 performance, where GDP growth reached 7.7%1. General Insurance sector achieved 10.9% growth in Gross Direct Premium, accelerating from 8.8% in Q1’FY2026. Health segment (including PA) demonstrated a stellar 22.4% growth, up from the 10.3% seen in Q1’FY2026. In Q1’FY2027, Niva Bupa grew 31.7% y-o-y on 1/n basis, to achieve GWP ₹ 2,150 crore. PAT for Q1’FY2027 was ₹ 137.8 crore near to doubling from ₹ 71.4 crore in Q1’FY2026 as per Ind AS reporting. Combined insurance service ratio (CISR) for Q1’FY2027 was 100.2% compared to 103.2% in Q1’FY2026. Our Q1’FY2027 Retail Health market share is at 11.1%, improving from 10.0% in Q1’FY2026. In line with the IRDAI regulation effective April 1, 2026, we have transitioned to Indian Accounting Standards (Ind AS) starting from Q1’FY2027. We view this shift as a significant milestone, as the enhanced disclosure framework meaningfully elevates financial transparency and aligns reporting practices with global benchmarks. Niva Bupa has been ranked 41st among India’s Top 100 Great Places to Work 2026, improving from 67th rank last year. We won “The Best Print Ad at the Marketer’s Excellence Awards 2026” by Afaqs ; “The Best New Product Launch” & “The Best Festive Marketing” at the BW Marketing Merit Awards 2026. Our Weighted Episodal NPS for Q1’FY2027 was 62, an improvement of 5 points over Q1’FY2026, reflecting our continued pursuit of service excellence. Combined Insurance Service Ratio (CISR) is calculated by the sum of Insurance service expenses, Net expenses from reinsurancecontract & Other operating expenses divide by Insurance revenue 4 1 Source: Provisional Estimates of GDP 2025-26 (www.pib.gov.in) Executive Summary Q1’FY27 (₹ in Crores) GWP1 GWP Profit/(Loss) After Tax Combined Insurance Claims Settlement Ratio (With 1/n) (Without 1/n) (Ind AS) Service Ratio (Ind AS) Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 ₹1,631.9 ₹2,150.0 ₹1,874.6 ₹2,306.2 71.4 137.8 103.2% 100.2% 93.6% 95.6% +31.7% +23.0% +92.9% Retail Health Market Renewal Rate for Retail Retail Health GWP1 Retail Health GWP Share1 Health Indemnity2 Weighted Episodal NPS (With 1/n) (Without 1/n) (With 1/n) (Without 1/n) Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 ₹1,092.4 ₹1,607.1 ₹1,302.3 ₹1,764.4 10.0% 11.1% 92.5% 95.8% 57 62 +47.1% +35.5% 1W.e.f. October 1, 2024 Long-term products are accounted on 1/n, as mandated by IRDAI, hence Q1’FY27 & Q1’FY26 numbers are not comparable with prior periods 5 2Renewal rate is calculated on total premium realized from the policies which are renewed in the relevant fiscal period Agenda Our Strategy Financial Performance Our Strategy 1 2 3 4 5 6 Building a Disciplined Multi-Channel & Granular, Growth Underwriting & Health Partner of Diversified Technology & Focus on Talent Oriented and Claims Choice for Distribution with Analytics Driven Management & Profitable Health Management, Customers Emphasis on Business Model Execution Insurance Underpinned by Digital Sales Franchise Expertise Key Performance Indicators Particulars Unit FY2025 FY2026 Q1’FY2026 Q1’FY2027 Gross Written Premium (₹ in Crores) 6,762.2 8,585.9 1,631.9 [Showing first 8,000 characters — download PDF for full document]